✦ LIBER ✦

Estramustine phosphate in prostate cancer: EORTC experience: Preliminary results of protocol 30762

✍ Scribed by P.H. Smith; M. Robinson; B. Richards; S. Suciu; M. de Pauw; R. Sylvester; L. Denis

Book ID: 119486050
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 345 KB
Volume: 23
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(84)80101-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Do Bone Scans Predict Prognosis in Prost

Do Bone Scans Predict Prognosis in Prostatic Cancer? A Report of the EORTC Protocol 30762

✍ F. LUND; P. H. SMITH; S. SUCIU; EORTC UROLOGICAL GROUP, 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

Estramustine phosphate as primary therap

Estramustine phosphate as primary therapy for metastatic prostate cancer: Preliminary results of the University of Wisconsin Trial

✍ Ralph C. Benson Jr. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Preliminary results of phase III study o

Preliminary results of phase III study of mitomycin C versus estramustine in progressive metastatic prostate cancer refractory to hormonal therapy — results of EORTC GU group study no. 30865

✍ Newling, D.; Fossa, S.; Tunn, U.; Kurth, K.H.; Pauw, M.de; Sylvester, R. 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 130 KB

Weekly paclitaxel, estramustine phosphat

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma : Results of a Minnie Pearl Cancer Research Network Phase II Trial

✍ Anthony A. Meluch; F. Anthony Greco; Lisa H. Morrissey; Eric L. Raefsky; Ronald 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objective of the current study was to evaluate the efficacy and toxicity of weekly paclitaxel, oral etoposide, and estramustine phosphate in the treatment of patients with advanced, hormone‐refractory prostate carcinoma. ## METHODS Patients with hormone‐refractory p

203 Permanent radioiodine seed implant i

203 Permanent radioiodine seed implant in clinically localized prostate cancer: Preliminary results of first 12 months of experience at Cancer Care Manitoba

✍ A. Dubey; A. Chowdhury; J. Bews 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Orchidectomy versus buserelin in combina

Orchidectomy versus buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843

✍ de Voogt, H.J.; Klijn, J.G.M.; Studer, U.; Schröder, F.; Sylvester, R.; De Pauw, 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 302 KB